Published By : 19 Dec 2017 | Published By : QYRESEARCH
New research has the say that ketamine could better tackle suicidal thoughts than conventional sedatives. The anesthetic drug has been previously studied to be an effective antidepressant. However, this study has looked at its impact on suicidal thoughts in particular and noted positive effects only within 24 hours. New York’s Columbia University Medical Center team has said that the drug could be a promising alternative for existing medication intended to treat suicidal tendencies. Patients with depression could be treated with ketamine as a rapidly acting treatment to reduce suicidal thoughts in them, as per Michael Grunebaum, psychiatrist and lead researcher.
However, ketamine could have a couple of known side effects – antidepressant effects lasting for a week, which challenges catheter or needle treatments and increase in blood pressure.
U.S. Suicide Rates Spiked 26.5% between 1999 and 2015
The new research had been conducted with the help of 80 volunteering participants actively considering suicide. Here, a low dose of ketamine had been put up against midazolam, a sedative. After a period of 24 hours, ketamine had been found to be more effective in controlling suicidal thoughts. A third of ketamine’s effect had specifically targeted suicidal thoughts, the researchers found after its general antidepressant qualities were factored in. Furthermore, the positive effects had still been evident even after six weeks the initial dose had been administered. In conclusion, ketamine had been found to be relatively safe, last for a significant time, and work fast.
However, ketamine has not yet been approved as an antidepressant, although one such drug has been knocking at the door of the U.S. Food and Drug Administration (FDA) for the official green light.